mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.7 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.7 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |